News Shortcuts from other journals

Fludarabine plus cyclophosphamide prolongs disease-free survival in CLL

BMJ 2007; 335 doi: (Published 26 July 2007) Cite this as: BMJ 2007;335:178

The combination of fludarabine and cyclophosphamide should be the standard treatment for chronic lymphocytic leukaemia (CLL), write British researchers. Patients treated with the combination had significantly longer progression-free survival than controls given fludarabine or chlorambucil in a trial comprising 777 mostly …

View Full Text

Log in

Log in through your institution


* For online subscription